BC
FLGT icon

BIT Capital’s Fulgent Genetics FLGT Stock Holding History

BIT Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,425
Closed -$244K – 168
2021
Q4 		$244K Hold
2,425
– – 0.02% 106
2021
Q3 		$218K Hold
2,425
– – 0.01% 89
2021
Q2 		$224K Hold
2,425
– – 0.01% 83
2021
Q1 		$234K Hold
2,425
– – 0.02% 62
2020
Q4 		$126K Hold
2,425
– – 0.02% 46
2020
Q3 		$97.1K Hold
2,425
– – 0.03% 46
2020
Q2 		$38.8K Buy
+2,425
New +$37.1K 0.02% 40

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT Capital's FLGT Position: Q1 2022 in Review

BIT Capital sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 2,425 shares — an estimated $244K sold.

BIT Capital first reported a position in FLGT in Q2 2020 and held it in 7 quarters. The position peaked at $244K in Q4 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • BIT Capital reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • BIT Capital sold 2,425 Fulgent Genetics shares in Q1 2022, an estimated $244K.
  • BIT Capital first reported a position in Fulgent Genetics in Q2 2020 and held it in 7 quarters.
  • BIT Capital's Fulgent Genetics position peaked at $244K in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on BIT Capital's 13F filing for Q1 2022, filed 12 Feb 2025.